241 related articles for article (PubMed ID: 24958470)
1. IL-1β-mediated repression of microRNA-101 is crucial for inflammation-promoted lung tumorigenesis.
Wang L; Zhang LF; Wu J; Xu SJ; Xu YY; Li D; Lou JT; Liu MF
Cancer Res; 2014 Sep; 74(17):4720-30. PubMed ID: 24958470
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
[TBL] [Abstract][Full Text] [Related]
3. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
Yu SH; Zhang CL; Dong FS; Zhang YM
J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230
[TBL] [Abstract][Full Text] [Related]
4. IL-1β-Mediated Up-Regulation of WT1D via miR-144-3p and Their Synergistic Effect with NF-κB/COX-2/HIF-1α Pathway on Cell Proliferation in LUAD.
Wu C; Li X; Zhang D; Xu B; Hu W; Zheng X; Zhu D; Zhou Q; Jiang J; Wu C
Cell Physiol Biochem; 2018; 48(6):2493-2502. PubMed ID: 30121641
[TBL] [Abstract][Full Text] [Related]
5. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-429 induces tumorigenesis of human non-small cell lung cancer cells and targets multiple tumor suppressor genes.
Lang Y; Xu S; Ma J; Wu J; Jin S; Cao S; Yu Y
Biochem Biophys Res Commun; 2014 Jul; 450(1):154-9. PubMed ID: 24866238
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory Effects of Phyllanthus emblica L on Benzopyrene-Induced Precancerous Lung Lesion by Regulating the IL-1β/miR-101/Lin28B Signaling Pathway.
Wang CC; Yuan JR; Wang CF; Yang N; Chen J; Liu D; Song J; Feng L; Tan XB; Jia XB
Integr Cancer Ther; 2017 Dec; 16(4):505-515. PubMed ID: 27562754
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-206 attenuates the growth and angiogenesis in non-small cell lung cancer cells by blocking the 14-3-3ζ/STAT3/HIF-1α/VEGF signaling.
Xue D; Yang Y; Liu Y; Wang P; Dai Y; Liu Q; Chen L; Shen J; Ju H; Li Y; Tan Z
Oncotarget; 2016 Nov; 7(48):79805-79813. PubMed ID: 27806334
[TBL] [Abstract][Full Text] [Related]
9. Synaptic acetylcholinesterase targeted by microRNA-212 functions as a tumor suppressor in non-small cell lung cancer.
Lu L; Zhang X; Zhang B; Wu J; Zhang X
Int J Biochem Cell Biol; 2013 Nov; 45(11):2530-40. PubMed ID: 23974008
[TBL] [Abstract][Full Text] [Related]
10. MiR-1 targets PIK3CA and inhibits tumorigenic properties of A549 cells.
Yu QQ; Wu H; Huang X; Shen H; Shu YQ; Zhang B; Xiang CC; Yu SM; Guo RH; Chen L
Biomed Pharmacother; 2014 Mar; 68(2):155-61. PubMed ID: 24486107
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-16 promotes growth and motility by targeting HDGF in non-small cell lung cancer cells.
Ke Y; Zhao W; Xiong J; Cao R
FEBS Lett; 2013 Sep; 587(18):3153-7. PubMed ID: 23954293
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-26a involved in Toll-like receptor 9‑mediated lung cancer growth and migration.
Jiang DS; Wang YW; Jiang J; Li SM; Liang SZ; Fang HY
Int J Mol Med; 2014 Jul; 34(1):307-12. PubMed ID: 24788552
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor.
Liu L; Shao X; Gao W; Zhang Z; Liu P; Wang R; Huang P; Yin Y; Shu Y
FEBS J; 2012 Oct; 279(20):3800-12. PubMed ID: 22883469
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Integrative Analysis Reveals the Association of
Arora S; Singh P; Ahmad S; Ahmad T; Dohare R; Almatroodi SA; Alrumaihi F; Rahmani AH; Syed MA
Cells; 2021 Aug; 10(8):. PubMed ID: 34440860
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of IL-11, an IL-6 Family Cytokine, Promotes Tumor Progression and Correlates with Poor Prognosis in Non-Small Cell Lung Cancer.
Zhao M; Liu Y; Liu R; Qi J; Hou Y; Chang J; Ren L
Cell Physiol Biochem; 2018; 45(6):2213-2224. PubMed ID: 29550807
[TBL] [Abstract][Full Text] [Related]
16. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.
Chung LY; Tang SJ; Sun GH; Chou TY; Yeh TS; Yu SL; Sun KH
Clin Cancer Res; 2012 Aug; 18(15):4037-47. PubMed ID: 22696230
[TBL] [Abstract][Full Text] [Related]
17. PYCR1 promotes the progression of non-small-cell lung cancer under the negative regulation of miR-488.
Wang D; Wang L; Zhang Y; Yan Z; Liu L; Chen G
Biomed Pharmacother; 2019 Mar; 111():588-595. PubMed ID: 30605882
[TBL] [Abstract][Full Text] [Related]
18. Long-term exposure to IL-1beta enhances Toll-IL-1 receptor-mediated inflammatory signaling in murine airway hyperresponsiveness.
Zhang Y; Xu CB; Cardell LO
Eur Cytokine Netw; 2009 Sep; 20(3):148-56. PubMed ID: 19825525
[TBL] [Abstract][Full Text] [Related]
19. MiR-142-3p represses TGF-β-induced growth inhibition through repression of TGFβR1 in non-small cell lung cancer.
Lei Z; Xu G; Wang L; Yang H; Liu X; Zhao J; Zhang HT
FASEB J; 2014 Jun; 28(6):2696-704. PubMed ID: 24558198
[TBL] [Abstract][Full Text] [Related]
20. C-myc/miR-150/EPG5 axis mediated dysfunction of autophagy promotes development of non-small cell lung cancer.
Li H; Liu J; Cao W; Xiao X; Liang L; Liu-Smith F; Wang W; Liu H; Zhou P; Ouyang R; Yuan Z; Liu J; Ye M; Zhang B
Theranostics; 2019; 9(18):5134-5148. PubMed ID: 31410206
[No Abstract] [Full Text] [Related]
[Next] [New Search]
